Eli Lilly and RNAi therapeutics specialist OliX Pharmaceuticals have entered into a global licensing agreement to advance a ...
Pfizer’s Takeda-partnered blood cancer drug Adcetris (brentuximab vedotin) has been approved by the US Food and Drug ...
The US Food and Drug Administration (FDA) has approved SpringWorks Therapeutics’ Gomekli (mirdametinib) to treat neurofibromatosis type 1 (NF1), a rare genetic disorder affecting approximately 100,000 ...
Eli Lilly has shared positive two-year results from an open-label extension (OLE) study of Omvoh (mirikizumab-mrkz) in active ...
Boehringer Ingelheim (BI) has announced positive top-line results from a late-stage study of its investigational ...
Novartis has announced that it will be expanding its late-stage cardiovascular pipeline by acquiring Anthos Therapeutics for ...
CSL Behring has shared positive four-year results from a late-stage study of its haemophilia B gene therapy Hemgenix ...
AbbVie has announced that the US Food and Drug Administration (FDA) has approved its Pfizer-partnered Emblaveo ...
Novo Nordisk has shared positive results from a late-stage study of its investigational haemophilia A therapy Mim8 in ...
An international clinical trial aimed at preventing Alzheimer’s disease (AD) in young adults who are at risk of developing ...
Roche’s Gazyva/Gazyvaro (obinutuzumab) has demonstrated superiority over standard therapy in patients with active lupus ...
Inizio has announced that it has appointed Jim Sage as president of Inizio Engage. Sage holds more than 25 years of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results